List of prodrugs

A prodrug is a chemical compound that, after administration, is metabolized (i.e. converted within the body) into a pharmacologically active substance.[1] Inactive prodrugs are pharmacologically inactive compounds that are metabolized into an active form within the body. Instead of administering a drug directly, a corresponding prodrug might be used instead to improve how a medicine is absorbed, distributed, metabolized, and excreted (ADME).

Prodrugs are often designed to improve bioavailability when a drug itself is poorly absorbed from the gastrointestinal tract. A prodrug may be used to improve how selectively the drug interacts with cells or processes that are not its intended target. This reduces adverse or unintended effects of a drug.

Prodrugs may be subject to a rate-limiting step in the conversion from inactive to active substance: in which case, only the duration, and not the intensity of the effect increases. Additionally, they may display other differences relating to pharmacokinetic factors (i.e. how a substance is absorbed, distributed, metabolized and excreted) compared its nonprodrug form.[citation needed]

Examples of recreational psychoactive substances that act as prodrugs include GBL (prodrug for GHB), psilocybin (prodrug for psilocin), ALD-52 (prodrug for LSD).

List

Depressants

Hallucinogens

Cannabinoids

Deliriants

Dissociatives

Psychedelics

Nootropics

Stimulants

Miscellaneous

Common misconceptions

Stimulants

See also

External links

References

  1. C. G. Wermuth, C. R. Ganellin, P. Lindberg, L. A. Mitscher; Ganellin; Lindberg; Mitscher (1998). "Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)". Pure and Applied Chemistry. 70 (5): 1129. https://doi.org/10.1351/pac199870051129
  2. Arbaclofen placarbil, a novel R-baclofen prodrug: improved absorption, distribution, metabolism, and elimination properties compared with R-baclofen. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/19502531
  3. The advantages of benzonal as an inducer of the liver mono-oxygenase enzyme system compared to phenobarbital. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/1305441
  4. Benzonal metabolism in guinea pigs. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/2792358
  5. Deposition of diazepam and its metabolites in hair following a single dose of diazepam. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/27534563
  6. Biotransformation and pharmacokinetics of ethylmorphine after a single oral dose. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/7654478
  7. https://erowid.org/archive/rhodium/chemistry/ghb.html#GHV
  8. Sawynok J (January 1986). "The therapeutic use of heroin: a review of the pharmacological literature". Can. J. Physiol. Pharmacol. 64 (1): 1–6. doi:10.1139/y86-001. PMID 2420426. 
  9. Morphine: pharmacokinetics and clinical practice. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/2245160
  10. Development of a sensitive method for the determination of oxycodone and its major metabolites noroxycodone and oxymorphone in human plasma by liquid chromatography-tandem mass spectrometry. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/26655109
  11. The excretion of pethidine and its derivatives (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1703639/
  12. <https://pubchem.ncbi.nlm.nih.gov/compound/826660/
  13. <https://pubchem.ncbi.nlm.nih.gov/compound/826660
  14. Metabolic profile of oxazepam and related benzodiazepines: clinical and forensic aspects. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/28903606
  15. Recent Advances in Anaesthesia and Intensive Care | https://books.google.co.uk/books?id=ei1edut0AqAC&pg=PA42&redir_esc=y#v=onepage&q&f=false
  16. 16.0 16.1 16.2 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/19515014
  17. https://www.erowid.org/library/books_online/pihkal/pihkal062.shtml
  18. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874698/
  19. Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/8496826
  20. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/17132243
  21. (S)-(-)-Cotinine, the major brain metabolite of nicotine, stimulates nicotinic receptors to evoke [3H]dopamine release from rat striatal slices in a calcium-dependent manner. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/10027825
  22. 22.0 22.1 Active drug metabolites. An overview of their relevance in clinical pharmacokinetics. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/2861928
  23. Metabolites of naloxone in human urine. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/5129377
  24. Atypical Psychotropic Agents | https://books.google.at/books?id=KfHEDgAAQBAJ&pg=PA460&redir_esc=y#v=onepage&q&f=false
  25. Comparative Pharmacology of Risperidone and Paliperidone. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/2861928
  26. Engberg, G. O. R. A. N., Elebring, T. H. O. M. A. S., & Nissbrandt, H. (1991). Deprenyl (selegiline), a selective MAO-B inhibitor with active metabolites; effects on locomotor activity, dopaminergic neurotransmission and firing rate of nigral dopamine neurons. Journal of Pharmacology and Experimental Therapeutics, 259(2), 841-847.
  27. Determination of aminorex in human urine samples by GC-MS after use of levamisole. (PubMed.gov / NCBI) | https://www.ncbi.nlm.nih.gov/pubmed/21531521